Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.
Right arrow Articles by Epstein, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.
Right arrow Articles by Epstein, P. N.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:2040-2046, 2001
© 2001 by the American Diabetes Association, Inc.

Overexpression of Metallothionein in Pancreatic ß-Cells Reduces Streptozotocin-Induced DNA Damage and Diabetes

Hainan Chen1, Edward C. Carlson2, Lori Pellet3, Jon T. Moritz3, and Paul N. Epstein1

1 Department of Pediatrics, University of Louisville, Louisville, Kentucky
2 Department of Anatomy and Cell Biology, University of North Dakota, Grand Forks, North Dakota
3 Department of Pharmacology, Physiology and Therapeutics, University of North Dakota, Grand Forks, North Dakota

The release of reactive oxygen species (ROS) has been proposed as a cause of streptozotocin (STZ)-induced ß-cell damage. This initiates a destructive cascade, consisting of DNA damage, excess activation of the DNA repair enzyme poly(ADP-ribose) polymerase, and depletion of cellular NAD+. Metallothionein (MT) is an inducible antioxidant protein that has been shown to protect DNA from chemical damage in several cell types. Therefore, we examined whether overexpression of MT could protect ß-cell DNA and thereby prevent STZ-induced diabetes. Two lines of transgenic mice were produced with up to a 30-fold elevation in ß-cell MT. Cultured islets from control mice and MT transgenic mice were exposed to STZ. MT was found to decrease STZ-induced islet disruption, DNA breakage, and depletion of NAD+. To assess in vivo protection, transgenic and control mice were injected with STZ. Transgenic mice had significantly reduced hyperglycemia. Ultrastructural examination of islets from STZ-treated mice showed that MT prevented degranulation and cell death. These results demonstrate that MT can reduce diabetes and confirm the DNA damage mechanism of STZ-induced ß-cell death.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
X. Li, H. Chen, and P. N. Epstein
Metallothionein and Catalase Sensitize to Diabetes in Nonobese Diabetic Mice: Reactive Oxygen Species May Have a Protective Role in Pancreatic {beta}-Cells
Diabetes, June 1, 2006; 55(6): 1592 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. E. Larrieta, P. Vital, A. Mendoza-Rodriguez, M. Cerbon, and M. Hiriart
Nerve Growth Factor Increases in Pancreatic {beta} Cells After Streptozotocin-Induced Damage in Rats.
Experimental Biology and Medicine, April 1, 2006; 231(4): 396 - 402.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. G. Cherian and Y. J. Kang
Metallothionein and Liver Cell Regeneration
Experimental Biology and Medicine, February 1, 2006; 231(2): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Wang, S. S. Lee, C. Dell'Agnello, V. Tchipashvili, J. D'Avilla, E. Czismadia, B. Y. Chin, and F. H. Bach
Bilirubin Can Induce Tolerance to Islet Allografts
Endocrinology, February 1, 2006; 147(2): 762 - 768.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Scheede-Bergdahl, M. Penkowa, J. Hidalgo, D. B. Olsen, P. Schjerling, C. Prats, R. Boushel, and F. Dela
Metallothionein-Mediated Antioxidant Defense System and Its Response to Exercise Training Are Impaired in Human Type 2 Diabetes
Diabetes, November 1, 2005; 54(11): 3089 - 3094.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. Penkowa, P. Keller, C. Keller, J. Hidalgo, M. Giralt, and B. K. Pedersen
Exercise-induced metallothionein expression in human skeletal muscle fibres
Exp Physiol, July 1, 2005; 90(4): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Chen, X. Li, and P. N. Epstein
MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity
Diabetes, May 1, 2005; 54(5): 1437 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
P. Schott-Ohly, A. Lgssiar, H.-J. Partke, M. Hassan, N. Friesen, and H. Gleichmann
Prevention of Spontaneous and Experimentally Induced Diabetes in Mice With Zinc Sulfate-Enriched Drinking Water Is Associated with Activation and Reduction of NF-{kappa}B and AP-1 in Islets, Respectively
Experimental Biology and Medicine, December 1, 2004; 229(11): 1177 - 1185.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. G. Jeong, C.-K. Youn, H.-J. Cho, S.-H. Kim, M.-H. Kim, H.-B. Kim, I.-Y. Chang, Y.-S. Lee, M.-H. Chung, and H. J. You
Metallothionein-III Prevents {gamma}-Ray-induced 8-Oxoguanine Accumulation in Normal and hOGG1-depleted Cells
J. Biol. Chem., August 13, 2004; 279(33): 34138 - 34149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Li, H. Chen, and P. N. Epstein
Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species
J. Biol. Chem., January 2, 2004; 279(1): 765 - 771.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.